Market Herald logo


Be the first with the news that moves the market

The Chinese Food and Drug Administration has approved CardieX’s Oscar 2 blood pressure monitor. With more than 12 percent of annual adult deaths resulting from hypertension, this device will be used by over 20,000 physicians to detect, diagnose, monitor and manage it.

It will measure central aortic blood pressure and conduct a central pressure waveform analysis. Patients will be able to monitor blood pressure over a 24-hour period at home with results being sent to doctors and then discussed.

The monitor features SphygmoCor technology, supplied by CardieX’s subsidiary AtCor, and is manufactured by SunTech Medical.

CardieX is also looking to create additional partnerships for in-home vital sign monitoring, home-use blood pressure monitoring, digital health, and smart health wearables.

CardieX CEO Craig Cooper hopes that this partnership will benefit those experiencing hypertension.

“This collaboration highlights the way CardieX aims to develop, grow and expand into the largest and most significant health market in the world,” he said.

Earning revenue of more than $USD50 million per annum this is expected to roll out in China in the second half of 2019.

Please find the announcement here

Chart image:

CDX by the numbers
More From The Market Herald

" Creso Pharma (ASX:CPH) signs potential partnership with Gotro for Sierra pet products

Creso Pharma (ASX:CPH) signs a heads of agreement with leading pet care distributor, Gotro Global, to…
Spirit Technologies (ASX:ST1) - CEO and MD Julian Challingsworth

" Spirit Technology (ASX:ST1) appoints Julian Challingsworth as CEO and MD

Spirit Technology (ASX:ST1) has appointed Julian Challingsworth as its new CEO and Managing Director, effective immediately.
The Market Herald Video

" Elsight (ASX:ELS) receives Halo order from Brazilian UAV services provider

Elsight (ASX:ELS) has received an initial order from Speedbird Aero, a leading Brazil-based comprehensive unmanned aerial…
The Market Herald Video

" Redflow (ASX:RFX) prepares for first sale of Gen3 batteries

Production of Redflow's (ASX:RFX) Gen3 battery begins ahead of the company's first commercial sale.